Sector Expert: Alain Vertes

NxR Biotechnologies GmbH

Image: Alain Vertes

Alain Vertès, Ph.D., M.B.A., is managing director of Basel, Switzerland-based NxR Biotechnologies, a consultancy that assists companies in funding, positioning and commercializing biotech products. He is an active business development consultant focused on technology deployment and innovation funding and commercialization. He has contributed to research (molecular biology, microbiology, sustainable chemistry), manufacturing (amino acids, enzymes), contract research (Battelle Memorial Institute, PPD), and strategic alliances in pharmaceuticals (Roche, Pfizer, Lilly), petrochemicals (Mitsubishi Chemical Corp.), industrial biotechnology, public research and consulting. With worldwide experience in partnering and licensing groups of big pharmas, Vertes has led reviews of strategic needs for finding, implementing and managing partnerships, from licensing to M&As. With hands-on involvement in the deployment of radical innovation—for example, bringing to patients disease-modifying, paradigm-changing therapeutics—he has managed major siRNA alliances and has led global therapeutic stem cell initiatives.



Recent Quotes

"MSB's technology is rock solid."

The Life Sciences Report Interview with Alain Vertès (3/17/15)
more >

"Right now, RP is positioned with very good potential."

The Life Sciences Report Interview with Alain Vertès (3/17/15)
more >

"ATHX's Multistem could very well be among the first few products approved in Japan."

The Life Sciences Report Interview with Alain Vertès (3/17/15)
more >



Due to permission requirements, not all quotes are shown.